Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Celiac Disease peptide trials
6 selected ClinicalTrials.gov records carrying the official condition label Celiac Disease. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
6 selected records.
1 profiles.
2017–2017 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 5 selected PubMed records and 0 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Celiac Disease unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00362856
PeptideScanner retained ClinicalTrials.gov record NCT00362856 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-12, and PeptideScanner's reviewed identity mapping was larazotide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 12, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00386165
PeptideScanner retained ClinicalTrials.gov record NCT00386165 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-11, and PeptideScanner's reviewed identity mapping was larazotide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 11, 2017
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00492960
PeptideScanner retained ClinicalTrials.gov record NCT00492960 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-20, and PeptideScanner's reviewed identity mapping was larazotide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- September 20, 2017
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Larazotide · 2017-09-20
ClinicalTrials.gov record NCT00492960
Completed at the retained observation.
Open attributed record →Larazotide · 2017-09-20
ClinicalTrials.gov record NCT00620451
Completed at the retained observation.
Open attributed record →Larazotide · 2017-09-20
ClinicalTrials.gov record NCT00889473
Completed at the retained observation.
Open attributed record →Larazotide · 2017-09-20
ClinicalTrials.gov record NCT01396213
Completed at the retained observation.
Open attributed record →Larazotide · 2017-09-12
ClinicalTrials.gov record NCT00362856
Completed at the retained observation.
Open attributed record →Larazotide · 2017-09-11
ClinicalTrials.gov record NCT00386165
Completed at the retained observation.
Open attributed record →